Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

被引：145
|
作者：
Brownlee, Wallace [1 ]
Bourdette, Dennis [2 ]
Broadley, Simon [3 ]
Killestein, Joep [4 ]
Ciccarelli, Olga [1 ,5 ]
机构：
[1] UCL Queen Sq Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, London, England
[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
[3] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast Campus, Nathan, Qld, Australia
[4] Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands
[5] Univ Coll London Hosp NIHR Biomed Res Ctr, London, England
来源：
NEUROLOGY | 2020年 / 94卷 / 22期
关键词：
D O I：
10.1212/WNL.0000000000009507
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The emergence of novel coronavirus 2019 (COVID-19)(1)and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).
引用
收藏
页码：949 / 952
页数：4
相关论文
共 50 条
  • [41] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    Siritho, Sasitorn
    Rattanathamsakul, Natthapon
    Detweeratham, Thammachet
    Prayoonwiwat, Naraporn
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [42] Epidemiology of multiple sclerosis and neuromyelitis optica spectrum disorder in South Korea
    Kim, J.
    Seok, J. M.
    Lee, H. J.
    Kim, B. J.
    Min, J. -H.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 610 - 610
  • [43] Diagnostic Challenges in Pediatric Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Yeshokumar, Anusha K.
    Banwell, Brenda L.
    JOURNAL OF PEDIATRIC NEUROLOGY, 2018, 16 (03) : 185 - 191
  • [44] Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea
    Kim, Jee-Eun
    Park, Sang-Hyun
    Han, Kyungdo
    Kim, Ho-Jin
    Shin, Dong-Wook
    Kim, Sung-Min
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (14) : 1837 - 1844
  • [45] The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk
    Yin, Hexiang
    Zhang, Yao
    Xu, Yan
    Peng, Bin
    Cui, Liying
    Zhang, Shuyang
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [46] Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report
    Lisa Lohmann
    Felix Glaser
    Gabriel Möddel
    Jan D. Lünemann
    Heinz Wiendl
    Luisa Klotz
    BMC Neurology, 22
  • [47] Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report
    Lohmann, Lisa
    Glaser, Felix
    Moeddel, Gabriel
    Luenemann, Jan D.
    Wiendl, Heinz
    Klotz, Luisa
    BMC NEUROLOGY, 2022, 22 (01)
  • [48] The psychological effect of Covid19 pandemic on neuromyelitis optica spectrum disorder patients and their attitude change during the pandemic, after a year
    Mehdipour, Roshanak
    Ashtari, Fereshteh
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [49] Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations
    Guevara, Carlos
    Villa, Eduardo
    Silva Rosas, Carlos
    Diaz, Violeta
    Naves, Rodrigo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [50] Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder
    Nakazawa, Kanako
    Noda, Takamasa
    Ichikura, Kanako
    Okamoto, Tomoko
    Takahashi, Yuji
    Yamamura, Takashi
    Nakagome, Kazuyuki
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 309 - 315
12345